CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Diagnostics

Image courtesy Everist Genomics

Everist Announces Advance In Diagnosis, Prognosis Of Colorectal Cancer

Everist Genomics, a rapidly growing personalized medicine company, today announced the launch of the world’s first comprehensive companion diagnostics and prognostics portfolio to improve early diagnosis, management and treatment of patients with colorectal cancer.

WWJ Newsradio 950–03/14/2012

rubicon

Rubicon Genomics Signs Deal For Technology With Agendia

Ann Arbor-based Rubicon Genomics Inc. said Thursday that it had a new clinical supply agreement with the Amsterdam, Netherlands-based diagnostics firm Agendia.

WWJ Newsradio 950–02/23/2012

Follow

Get every new post delivered to your Inbox.

Join 1,886 other followers